Tobias S. Slordahl
Trondheim, 7030, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Clozapine - evidence and practice out of step.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: September 08, 2026
High-dose melphalan and autologous haematopoietic stem cell transplantation in multiple myeloma in Norway, 2008-2020.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: April 21, 2026
Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.
Journal: American journal of hematology
Published: March 09, 2026
Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.
Journal: British journal of haematology
Published: February 20, 2026
Light Chain Deposition Disease - presenting with Cystic Pulmonary Disorder as primary manifestation - A case report.
Journal: Respiratory medicine case reports
Published: October 31, 2025
To substitute or not? A systematic review of immunoglobulin replacement therapy in multiple myeloma patients treated with bispecific antibodies.
Journal: Frontiers in immunology
Published: October 10, 2025
Multiplexed Imaging Reveals Immune-Metabolic Niches in Multiple Myeloma Linked to Progression and Bone Disease.
Journal: Blood cancer discovery
Published: September 01, 2025
Optimizing lenalidomide therapy in renal impairment: analysis of renal response in the prospective REMNANT study in transplant-eligible newly diagnosed multiple myeloma.
Journal: Blood cancer journal
Published: August 19, 2025
Cytogenetic abnormalities in multiple myeloma patients according to age: A real-world study by the Nordic Myeloma Study Group.
Journal: British journal of haematology
Published: March 19, 2025
A Real-World International Staging System (RW-ISS) for patients with newly diagnosed multiple myeloma.
Journal: Blood cancer journal
Published: January 10, 2025
Novel PROTAC to target FKBP12: the potential to enhance bone morphogenetic protein activity and apoptosis in multiple myeloma.
Journal: Haematologica
Published: November 25, 2024
Combined Proteasome and Autophagy Inhibition in Relapsed/Refractory Multiple Myeloma-A Phase I Trial of Hydroxychloroquine, Carfilzomib, and Dexamethasone.
Journal: EJHaem
Published: November 19, 2024
Last Updated: 09/26/2026